Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
This article isn't asserting that these offers share legal ownership, come from the same manufacturer, or are part of a coordinated release strategy - that would require documentation this review doesn't have
J Clin Invest 133:e165654
Nov 1: Mercks blockbuster Keytruda racked up another FDA approval Wednesday, as the company announced that the anti-PD-1 therapy is now authorizedin combination with gemcitabine and cisplatinto treat patients with locally advanced unresectable or metastatic biliary tract cancer (BTC)
ZA and DJM are principal investigators and made contributions to the design of the study, acquisition (DJM) and interpretation of the data, and revision of the manuscript
While not ideal, a one-time accidental intramuscular injection is unlikely to cause serious harm
The platform integrates over 500 million patents, scientific publications, clinical trial records, and market intelligence sources through a proprietary R&D ontology purpose-built for technology scouting and competitive analysis
US$ 21.52
US$ 26.74
US$ 28.30
US$ 20.16
US$ 20.67
